Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ardelyx, Inc. - Common Stock (NQ:ARDX)

6.215 -0.085 (-1.35%)
Streaming Delayed Price Updated: 11:05 AM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
News headline image
Ardelyx to Participate at the Cowen 43rd Annual Health Care Conference
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
Ardelyx to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 2, 2023
Conference call scheduled for 4:30 p.m. Eastern Time 
From Ardelyx, Inc.
Via GlobeNewswire
News headline image
7 A-Rated Penny Stocks Worth Betting On ↗
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
News headline image
7 Stocks Under $10 to Buy in February ↗
A stock under $10 to buy is more likely to be a growth stock with a longer runway to providing investors with some great returns. 
Via InvestorPlace
News headline image
Why Ardelyx Shares Are Falling ↗
Ardelyx Inc (NASDAQ: ARDX) shares are trading lower by 17.03% to $2.67 Thursday morning after the company filed for a mixed shelf offering of up to $250 million. 
Via Benzinga
News headline image
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
News headline image
7 A-Rated Stocks to Buy for February 2023 ↗
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader. 
Via InvestorPlace
News headline image
7 A-Rated Stocks to Buy for Less Than $25 ↗
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market. 
Via InvestorPlace
News headline image
PPG Industries, Netflix, Ally Financial And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Nasdaq Composite gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
5 Under-the-Radar Penny Stocks With 100% Upside Potential ↗
Most experts will advise you to steer clear of under the radar penny stocks – and for good reason. However, keep an eye on these. 
Via InvestorPlace
News headline image
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like... 
Via Benzinga
News headline image
Ardelyx To Rally 160%? Here Are 10 Other Price Target Changes For Friday ↗
Citigroup raised Ardelyx, Inc. (NASDAQ: ARDX) price target from $6 to $7. Citigroup analyst Yigal Nochomovitz maintained a Buy rating on the stock. Ardelyx shares rose 9.4% to $2.7685 on Friday. 
Via Benzinga
News headline image
Dow Surges 250 Points; Jobless Claims Rise To 225,000 ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Thursday. 
Via Benzinga
News headline image
The 3 Biggest Opportunities for Penny Stock Investors in 2023 ↗
Investors should be able to profit from some of the biggest opportunities for penny stock investors identified in this column. 
Via InvestorPlace
News headline image
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
Via Benzinga
News headline image
Melco, Ardelyx And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Cosmos Health Inc. (NASDAQ: COSM) shares dipped 37.7% to $14.33 in... 
Via Benzinga
News headline image
FDA Needs More Time For Ardelyx's Appeal To Rejection Of Kidney Disease Candidate ↗
 
Via Benzinga
News headline image
Why Innate Pharma Shares Are Trading Higher By 24%; Here Are 34 Stocks Moving Premarket ↗
Gainers AIM ImmunoTech Inc. (NYSE: AIM) shares rose 82.4% to $0.62 in pre-market trading. AIM ImmunoTech recently reported safety, tolerability and biological activity data for intranasal ampligen in... 
Via Benzinga
News headline image
The 7 Hottest Biotech Stocks to Own in 2023 and Beyond ↗
Biotech is one of the safest, recession-proof sectors on the market. It's why we're going after the hottest biotech stocks in the New Year. 
Via InvestorPlace
News headline image
How Is The Market Feeling About Ardelyx? ↗
Ardelyx's (NASDAQ:ARDX) short percent of float has risen 16.96% since its last report. The company recently reported that it has 8.59 million shares sold short, which is 4.62% of all regular shares... 
Via Benzinga
News headline image
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive ↗
In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount... 
Via Benzinga
News headline image
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In November 2022: Where Do Tesla, Apple, A Donald Trump-Linked SPAC Rank? ↗
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
News headline image
3 Biotech Stocks Smart Investors Should Be Buying Up Now ↗
These three biotech stocks could be among the best ways to play this uncertain market for those looking for long-term growth. 
Via InvestorPlace
News headline image
Dollar Tree, Dycom Industries, Chico's FAS And Other Big Losers From Tuesday ↗
U.S. stocks closed higher on Tuesday, with the Dow Jones gaining around 400 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
News headline image
Is Ardelyx is A Buy After Slip in Early 2022
Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them 
Via MarketBeat
CapitalGainsReport Sector Spotlight: Healthcare Penny Stocks On The Move (ARDX, WHSI, BNGO)
Via AB Newswire
News headline image
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday ↗
Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. 
Via Benzinga
News headline image
Foot Locker, Ross Stores, Palo Alto Networks, And Other Big Gainers From Friday ↗
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
2 Biotech Stocks That Can Rocket Higher in 2023, According to Wall Street ↗
Recent analyst upgrades suggest these stocks can triple your money or better. 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.